MARKET

SRZN

SRZN

Surrozen Inc
NASDAQ
20.46
+2.23
+12.23%
After Hours: 20.76 +0.3 +1.47% 17:48 12/05 EST
OPEN
18.30
PREV CLOSE
18.23
HIGH
20.47
LOW
18.29
VOLUME
187.06K
TURNOVER
--
52 WEEK HIGH
20.47
52 WEEK LOW
5.90
MARKET CAP
175.37M
P/E (TTM)
-1.0356
1D
5D
1M
3M
1Y
5Y
1D
Surrozen Inc. Director and 10% Owner Tim Kutzkey Reports Acquisition of Common Shares
Reuters · 3d ago
Weekly Report: what happened at SRZN last week (1124-1128)?
Weekly Report · 5d ago
12 Health Care Stocks Moving In Friday's Pre-Market Session
Benzinga · 11/28 12:05
Surrozen to Present at Upcoming Healthcare Investor Conferences
Reuters · 11/25 21:05
Weekly Report: what happened at SRZN last week (1117-1121)?
Weekly Report · 11/24 09:37
Column Group Entities Report Acquisition of Surrozen Inc. Common Shares
Reuters · 11/18 00:16
Weekly Report: what happened at SRZN last week (1110-1114)?
Weekly Report · 11/17 09:38
Surrozen Inc. Files Initial Statement of Beneficial Ownership for Chief Financial Officer Andrew Pedrum Maleki
Reuters · 11/13 21:15
More
About SRZN
Surrozen, Inc. is a biotechnology company discovering and developing drug candidates to selectively modulate the Wnt pathway. The Company is developing tissue-specific antibodies designed to engage the body’s existing biological repair mechanisms with a focus in ophthalmology. Its product candidates include SZN-8141 for Retinal Diseases, SZN-8143 for Retinal Diseases, SZN-113 for Fuchs’ Endothelial Corneal Dystrophy and Geographic Atrophy, and SZN-413 for Retinal Diseases. SZN-8141 combines Frizzled 4 (Fzd4) agonism and Vascular Endothelial Growth Factor (VEGF) antagonism which has the potential to provide benefits over treatment with single agents for Diabetic Macular Edema (DME) and neovascular Age Related Macular Degeneration (wet AMD). SZN-8143 combines Fzd4 agonism, VEGF antagonism, and interleukin-6 (IL-6) antagonism which may have benefits over single agents for treatment of DME/wet AMD/uveitic macular edema. SZN-413 is a bi-specific antibody, designed using its SWAP technology.

Webull offers Surrozen Inc stock information, including NASDAQ: SRZN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SRZN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SRZN stock methods without spending real money on the virtual paper trading platform.